189 results
Page 2 of 10
8-K
EX-99.1
068l 1cr34g
9 Aug 23
NeuroBo Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:20pm
8-K
ejx 1nz59rnl9wlzv
29 Jun 23
Submission of Matters to a Vote of Security Holders
8:36am
8-K
EX-10.1
mvkss az8udb3w9xv8a
29 Jun 23
Submission of Matters to a Vote of Security Holders
8:36am
8-K
w19eg5
12 May 23
Departure of Directors or Certain Officers
8:13am
S-8
2arnnxw bvn39a4ivxl
17 Apr 23
Registration of securities for employees
4:35pm
8-K
EX-10.1
esjo28 746jquxekwa
22 Dec 22
Departure of Directors or Certain Officers
5:08pm
8-K
EX-10.2
kbwos
22 Dec 22
Departure of Directors or Certain Officers
5:08pm
8-K
EX-4.1
t1f06g3m3mnn62d
8 Nov 22
Neurobo Announces Pricing of $30 Million Underwritten Public Offering and Concurrent Private Placement
5:24pm
8-K
EX-4.2
em5jqa845
8 Nov 22
Neurobo Announces Pricing of $30 Million Underwritten Public Offering and Concurrent Private Placement
5:24pm
8-K
EX-1.1
llzrvlhyxy37j37
8 Nov 22
Neurobo Announces Pricing of $30 Million Underwritten Public Offering and Concurrent Private Placement
5:24pm
8-K
EX-4.4
khv2u6
8 Nov 22
Neurobo Announces Pricing of $30 Million Underwritten Public Offering and Concurrent Private Placement
5:24pm
8-K
EX-4.3
9m8yz9d
8 Nov 22
Neurobo Announces Pricing of $30 Million Underwritten Public Offering and Concurrent Private Placement
5:24pm